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Abstract 
The evidence-based model is crucial to contemporary healthcare. It is dependent on 
systematic review methodology modelled on an arguably out-dated hierarchy of evidence. 
There has been a significant increase in medical and health research using qualitative and 
mixed method designs. The perspective taken in this article is that we need to broaden our 
evidence base if we are to fully take account of issues of context, acceptability and feasibility 
in the development and implementation of healthcare interventions. One way of doing this is 
to use a range of methods which better fit the different aspects of intervention development 
and implementation. Methods for the systematic review of evidence other than randomized 
controlled trials are available and there is a readiness to incorporate these other types of 
evidence into good-practice guidance, but we need a clear methodology and to translate 
these advances in research into the world of policy. 
 
Delivering evidence-based healthcare is a complex interpersonal process 
Evidence-based healthcare (EBHC) depends on collating research evidence, communicating 
findings, and translating findings into best practice guidance which can be implemented in 
real-world practice. Cochrane’s definition of EBHC highlights the centrality of the clinician-
evidence relationship to bridge the gap between research and practice (see: 
http://www.cochrane.org/about-us/evidence-based-health-care#REF1). How clinicians feel 
about evidence can impact on the degree of fidelity with which healthcare interventions are 
implemented.[1] As such there are critical differences between evidence of efficacy and 
effectiveness. All evidence based interventions, whether biomedical, social or structural, 
involve interpersonal processes and are “delivered in the context of an encounter between a 
health professional and a patient, making healthcare professional clinical behaviours an 
important proximal determinant of the quality of care that patients receive”.[2]  
Thus, interpersonal relationships and communication are fundamental to implementation 
science. This jars with most understandings of the role of evidence within guideline formation 
which disproportionately privileges large-scale population based studies. Such studies are 
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vital tests of efficacy and cost-effectiveness, yet poor at understanding implementation. The 
current evidence hierarchy used to help shape guidance production (e.g. by NICE and 
SIGN1) struggles to incorporate qualitative and mixed methods research, and thus lacks 
systematic analyses of the context and experience of implementing interventions. Clinicians 
and commissioners2 need to understand the interactions, relationships and sociocultural 
contexts which shape the acceptability and meaningfulness of healthcare interventions. To 
complete the cycle of translating findings into ‘practice-ready’ guidance it is necessary to 
consider the human systems within which an intervention is to be implemented. This is an 
iterative process, as described in the Medical Research Council’s (MRC) framework for 
developing complex behavioural interventions (see: 
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871).  
A complete evidence-base must inform healthcare guidance. This should: develop from a 
pluralistic model of research; address translational and implementation questions; draw upon 
different methods for different questions; provide diverse evidence on which to base best 
practice guidance.  
What’s missing from conventional accounts of how ‘best evidence’ informs 
practice?  
We know that within the hierarchy of evidence systematic reviews of randomized controlled 
trials (RCTs) sit at the top as the ‘gold standard’ and are key to informing guidance.[3] This is 
unsurprising because they report on efficacy and/or cost-effectiveness of interventions in 
terms which provide clear messages for policy makers. However, as Sackett’s discussion of 
evidence-based medicine made clear, when faced with an individual patient, an RCT may 
not provide coherent advice.[4] Instead, Sackett emphasised the need for both clinical 
expertise and current best evidence because without both, practice will suffer to the 
detriment of patients. Balancing insights from cumulative knowledge and taking a negotiated 
and tailored approach to each patient represents the best approach.  
Whilst the traditional hierarchy of evidence is vital in understanding cumulative knowledge 
and healthcare delivery, it is not without its shortcomings. The vital focus on objective, 
measurable and controllable ways of looking at healthcare at a population level mean that 
social context and individual experience are stripped away; the patient and the clinician are 
both reduced to cyphers. To be useful, best-practice guidance must be adaptable to real-
world practice scenarios, i.e. take account of the cultural and psychosocial context. This is 
the job of translational research which emphasizes working within real-world environments, 
partnerships, stakeholder consultations, and often involves qualitative and/or mixed methods 
designs.[5,6] 
Incorporating experience and context into healthcare evidence 
There has been a substantial rise in the use qualitative and mixed methods research in 
medical and healthcare settings in the last 20 years which has provided great insight into the 
                                                            
1 These denote the National Institute for Health and Care Excellence and the Scottish Intercollegiate 
Guideline Network.  
2 UK healthcare is devolved to member states. In England healthcare services are commissioned by 
the NHS Commissioning Board whose role it is to allocate funds to deliver the best possible care to 
patients. This is supported by regional Clinical Commissioning Groups made up of local practitioners 
whose responsibility it is to ensure that local services meet local needs (see: 
http://webarchive.nationalarchives.gov.uk/20130805112926/http://healthandcare.dh.gov.uk/system/).   
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value and accessibility of healthcare services.[7,8] Furthermore, it has shown us how 
patients make sense of their own health, whether health information provided is clear and 
appropriate, and whether healthcare professionals feel competent when explaining complex 
risks associated with diagnosis or treatment regimes.[9,10] 
Some ground has been gained in recent moves by funding bodies, particularly the UK 
government funding programme - National Institute for Health Research (NIHR) - to 
foreground patient perspectives in designing and conducting research through patient, carer 
and public involvement (PCPI; 
e.g.:http://www.crncc.nihr.ac.uk/about_us/stroke_research_network/in_your_area/south_wes
t/Patients_carers ). A review of patient involvement has demonstrated that it can be cost-
effective and has been adopted in a range of research designs including RCTs, naturalistic 
studies, participatory and political action research.[11,12] As such, PCPI has sanctioned the 
utility of patient and carer perspectives. Nevertheless, it remains an initiative to involve 
patients in the research process, rather than expanding the types of methods used in 
designing services. Patient perspectives remain absent from the process by which evidence 
becomes guidance. Although patients increasingly help set research agendas, unless their 
perspectives are turned into high quality peer reviewed papers they will not shape guidance 
production. 
The added value of qualitative and mixed methods research  
To incorporate experience and context into the evidence-base, alongside efficacy and cost-
effectiveness, and thus to provide useful best-practice guidance that can deal with multiple 
formulations at the population, systemic and individual levels, we require a wider range of 
research questions and methods, and a more balanced view of their value. Mixed methods 
designs and qualitative research offer systematic ways of exploring the socio-cultural context 
within which healthcare services must be designed and delivered; they provide means of 
gathering and analysing patients’ perspectives, features of interactions between patients and 
practitioners, language used in health information, and tools to understand patient 
expectations and satisfaction; and they can help us understand key relationships at the level 
of family, community, health and social care organisations, and government. NICE’s 
conceptual framework puts the patients’ lifeworld at the centre.[13] This refers to all of the 
socio-economic, cultural, and historical aspects of our lives; it includes our relationships, 
geography, and our ability to take control, or have agency, in our interactions with healthcare 
providers and policy makers. The centrality of the lifeworld requires that we are open to a 
broad range of research questions and designs and that we use the best-fit methods for the 
questions we are asking. This may involve multiple qualitative methods, qualitative and 
quantitative methods, or more than one quantitative method.[14] The outcomes of such 
research can help us to understand not only the role of experience and context in the 
implementation of interventions; they can also help us to develop future interventions, and 
future evaluations of the effectiveness of those interventions. They are therefore likely to be 
important to the users of research.[15] Critically then, the centrality of the lifeworld means 
that we must be open to including the outcomes of such research in syntheses of evidence, 
and in the development of guidance to inform best practice. 
Systematic reviews of diverse evidence  
The value of qualitative research is clear but there remains a gap between high quality 
primary qualitative research and its systematic review for inclusion in good-practice 
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guidance.[16] That is not to say that methods for systematically reviewing qualitative 
evidence do not exist.[17-]  Furthermore, UK bodies NICE and SIGN have declared their 
commitment to qualitative evidence as essential, alongside more ‘traditional’ (i.e. 
quantitative) sources of evidence, in understanding healthcare and subsequently in 
producing guidelines for best clinical practice. For this work to be translated into the policy 
and practice world, we need a clear methodology. The work of the Cochrane Collaboration 
Qualitative Methods and Implementation Group in the UK (see: http://cqim.cochrane.org/) 
and the Patient-Centered Outcomes Research Institute in the US (see: http://www.pcori.org/) 
have begun this work. Significant advancements in appraisal tools for diverse evidence 
exist[18] but focused efforts are required to establish rigorous methods for synthesis of 
quantitative and qualitative data. Integrative and aggregative synthesis methods have been 
proposed.[17] The EPPI3 approach involves the parallel synthesis of, for example, 
intervention studies (quantitative methods) and perspectives studies (qualitative methods). 
This is not an integrative approach because findings from studies with different designs are 
dealt with separately before being brought together in a ‘mosaic’ to answer the research 
question.[19] A recent proposal for ‘best-fit’ framework synthesis generates an a priori 
framework from literature describing conceptual models or theories. Next, deductive (using 
the framework) and inductive coding (data-driven) using principles of thematic analysis are 
used to perform the synthesis.[20] While currently proposed for the synthesis of qualitative 
evidence alone, there is potential to adapt this integrative method of synthesis for use with 
diverse evidence.  
Once a rigorous methodology for systematic review and synthesis of diverse evidence is 
recognised, the next challenge is determining how such evidence will manifest in best-
practice guidance. As indicated above, qualitative and mixed methods evidence will advise 
practitioners in their everyday encounters with patients in individual or group settings. 
Additionally, it will inform the development of strategies for desining interventions that are 
feasible in different contexts and that generate patient acceptance across a range of socio-
economic and geographical groupings. In short, incorporating diverse evidence into EBHC 
will produce guidance encompassing best-practice at the population, systemic and individual 
levels. 
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